Clinical Trial

Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors

Name: Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors — clinical trial record (NCT07624214)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is to evaluate the safety and tolerability of of LT-010391 as monotherapy in participants with KRAS G12D mutant advanced solid tumors

Trial Details

NCT Number	NCT07624214
Lead Sponsor	Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
Conditions	Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Enrollment	198 participants
Start Date	2026-07
Primary Completion	2028-04 (estimated)
Study Completion	2029-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-03